Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons

Significance According to the World Health Organization, tobacco consumption causes the death of close to 6 million people each year, yet successful attempts to quit smoking are very rare. The present study identifies a group of neurons in the brain that respond differently to nicotine after a period of abstinence, suggesting that altered activity of these neurons may contribute to difficulties with smoking cessation. The discovery of genetic variants in the cholinergic receptor nicotinic CHRNA5-CHRNA3-CHRNB4 gene cluster associated with heavy smoking and higher relapse risk has led to the identification of the midbrain habenula–interpeduncular axis as a critical relay circuit in the control of nicotine dependence. Although clear roles for α3, β4, and α5 receptors in nicotine aversion and withdrawal have been established, the cellular and molecular mechanisms that participate in signaling nicotine use and contribute to relapse have not been identified. Here, using translating ribosome affinity purification (TRAP) profiling, electrophysiology, and behavior, we demonstrate that cholinergic neurons, but not peptidergic neurons, of the medial habenula (MHb) display spontaneous tonic firing of 2–10 Hz generated by hyperpolarization-activated cyclic nucleotide-gated (HCN) pacemaker channels and that infusion of the HCN pacemaker antagonist ZD7288 in the habenula precipitates somatic and affective signs of withdrawal. Further, we show that a strong, α3β4-dependent increase in firing frequency is observed in these pacemaker neurons upon acute exposure to nicotine. No change in the basal or nicotine-induced firing was observed in cholinergic MHb neurons from mice chronically treated with nicotine. We observe, however, that, during withdrawal, reexposure to nicotine doubles the frequency of pacemaking activity in these neurons. These findings demonstrate that the pacemaking mechanism of cholinergic MHb neurons controls withdrawal, suggesting that the heightened nicotine sensitivity of these neurons during withdrawal may contribute to smoking relapse.

[1]  Nathaniel G Mahieu,et al.  The Disruption of Celf6, a Gene Identified by Translational Profiling of Serotonergic Neurons, Results in Autism-Related Behaviors , 2013, The Journal of Neuroscience.

[2]  H. Okamoto,et al.  Molecular characterization of the subnuclei in rat habenula , 2012, The Journal of comparative neurology.

[3]  Monica R. F. Hilário,et al.  Reward Sensitization: Effects of Repeated Nicotine Exposure and Withdrawal in Mice , 2012, Neuropsychopharmacology.

[4]  S. Cragg,et al.  Striatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum , 2012, The Journal of Neuroscience.

[5]  A. Grace,et al.  Shifting pharmacology of nicotine use and withdrawal: Breaking the cycle of drug abuse , 2012, Proceedings of the National Academy of Sciences.

[6]  D. van der Kooy,et al.  Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal , 2012, Proceedings of the National Academy of Sciences.

[7]  Dardo Tomasi,et al.  Addiction circuitry in the human brain. , 2012, Annual review of pharmacology and toxicology.

[8]  M. De Biasi,et al.  Mechanistic insights into nicotine withdrawal. , 2011, Biochemical pharmacology.

[9]  R. Veh,et al.  Lateral habenular neurons projecting to reward-processing monoaminergic nuclei express hyperpolarization-activated cyclic nucleotid-gated cation channels , 2011, Neuroscience.

[10]  U. Maskos,et al.  Aversion to Nicotine Is Regulated by the Balanced Activity of β4 and α5 Nicotinic Receptor Subunits in the Medial Habenula , 2011, Neuron.

[11]  G. Feng,et al.  Habenula “Cholinergic” Neurons Corelease Glutamate and Acetylcholine and Activate Postsynaptic Neurons via Distinct Transmission Modes , 2011, Neuron.

[12]  E. Cherubini,et al.  Nicotine Blocks the Hyperpolarization-Activated Current Ih and Severely Impairs the Oscillatory Behavior of Oriens-Lacunosum Moleculare Interneurons , 2010, The Journal of Neuroscience.

[13]  J. Changeux,et al.  Nicotine addiction and nicotinic receptors: lessons from genetically modified mice , 2010, Nature Reviews Neuroscience.

[14]  John P. Horn,et al.  Cav1.3 Channel Voltage Dependence, Not Ca2+ Selectivity, Drives Pacemaker Activity and Amplifies Bursts in Nigral Dopamine Neurons , 2009, The Journal of Neuroscience.

[15]  L. Ng,et al.  Brn3a and Nurr1 Mediate a Gene Regulatory Pathway for Habenula Development , 2009, The Journal of Neuroscience.

[16]  J. Boulter,et al.  Nicotinic Receptors in the Habenulo-Interpeduncular System Are Necessary for Nicotine Withdrawal in Mice , 2009, The Journal of Neuroscience.

[17]  M. Zoli,et al.  Rodent Habenulo–Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the α3β4* and α3β3β4* Subtypes Mediate Acetylcholine Release , 2009, The Journal of Neuroscience.

[18]  P. Greengard,et al.  Application of a Translational Profiling Approach for the Comparative Analysis of CNS Cell Types , 2008, Cell.

[19]  Daniel F. Gudbjartsson,et al.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.

[20]  J. Changeux,et al.  Differential Role of Nicotinic Acetylcholine Receptor Subunits in Physical and Affective Nicotine Withdrawal Signs , 2008, Journal of Pharmacology and Experimental Therapeutics.

[21]  Cecilia Gotti,et al.  Regulation of neuronal nicotinic receptor traffic and expression , 2007, Brain Research Reviews.

[22]  A. C. Collins,et al.  Guidelines on nicotine dose selection for in vivo research , 2007, Psychopharmacology.

[23]  B. Rusak,et al.  Circadian firing-rate rhythms and light responses of rat habenular nucleus neurons in vivo and in vitro , 2005, Neuroscience.

[24]  Su-Youne Chang,et al.  Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus , 2005, The Journal of comparative neurology.

[25]  R. Tyndale,et al.  Nicotine physical dependence and tolerance in the mouse following chronic oral administration , 2005, Psychopharmacology.

[26]  H. Tillmanns,et al.  Nicotine inhibits large conductance Ca2 + -activated K+ channels and the NO/-cGMP signaling pathway in cultured human endothelial cells , 2005, Scandinavian cardiovascular journal : SCJ.

[27]  E. Nestler Molecular mechanisms of drug addiction , 2004, Neuropharmacology.

[28]  D. Perry,et al.  Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long‐term but not short‐term nicotine treatment , 2004, Journal of neurochemistry.

[29]  A. C. Collins,et al.  Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment , 2004, Neuropharmacology.

[30]  M. Picciotto,et al.  Neuroprotection by Nicotine in Mouse Primary Cortical Cultures Involves Activation of Calcineurin and L-Type Calcium Channel Inactivation , 2003, The Journal of Neuroscience.

[31]  P. Greengard,et al.  The neurobiology of dopamine signaling , 2002, European Psychiatry.

[32]  S. Siegelbaum,et al.  Molecular and Functional Heterogeneity of Hyperpolarization-Activated Pacemaker Channels in the Mouse CNS , 2000, The Journal of Neuroscience.

[33]  A. Nordberg,et al.  Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  J. Changeux,et al.  Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.

[35]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[36]  F. Fonnum,et al.  Topography of cholinergic and substance P pathways in the habenulo-interpeduncular system of the rat. An immunocytochemical and microchemical approach , 1987, Neuroscience.

[37]  Robert J. Sutherland,et al.  The dorsal diencephalic conduction system: A review of the anatomy and functions of the habenular complex , 1982, Neuroscience & Biobehavioral Reviews.

[38]  Qun Lu,et al.  Habenular a5 nicotinic receptor subunit signalling controls nicotine intake , 2011 .

[39]  D. Mant,et al.  Nicotine replacement therapy for smoking cessation. , 2008, The Cochrane database of systematic reviews.

[40]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[41]  J. R. Pauly,et al.  Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice , 1999, Psychopharmacology.